Biosurgery Market Report Size, Industry Share and Forecast 2023-2028

IMARC Group, a leading market research company, has recently releases report titled “Biosurgery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the global biosurgery market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the biosurgery market?

Report Attributes	Details
Market Size in 2022	US$ 13.0 Billion
Market Forecast in 2028	US$ 19.5 Billion
Growth rate (2023 to 2028)	CAGR of 6.85%
Base Year of the Analysis	2022
Forecast Period	2023-2028

What is biosurgery?

Biosurgery is a medical practice of cleaning a wound or contaminated area with live organisms, such as larvae or maggots. It is extensively used to prevent excessive blood loss, provide adhesion for injury or tissue sealing, and repair damaged tissues and bones. It includes biological and synthetic materials used during surgery to eliminate complications, improve surgical practices, and meet various surgical needs, such as preventing excess bleeding, reducing the risks of infection, and debridement of the necrotic, slough, devitalized wounds or tissues and defects.

Request for a free sample copy of this report: https://www.imarcgroup.com/biosurgery-market/requestsample

What are the growth prospects and trends in the biosurgery industry?

The global market is majorly driven by the growing number of surgical procedures. In line with this, the availability of multifunctional products that accelerate healing and help reduce post-surgical recovery duration is positively influencing the market. Heavy investments by governments of various countries to boost public healthcare delivery are acting as another growth-inducing factor. Furthermore, the rising demand for effective patient blood loss management is catalyzing the market.

Moreover, the increasing health awareness, expanding healthcare expenditure, growing medical tourism, and fast improving healthcare infrastructure are offering numerous growth opportunities in the biosurgery market. Besides this, the high prevalence of diabetes and spinal injuries among the masses is propelling the demand for biosurgery. Additionally, the escalating demand for minimally invasive surgeries and a continual rise in the aging population with chronic conditions are strengthening the growth of the market. 

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Product:

• Bone-Graft Substitutes
• Soft-Tissue Attachments
• Hemostatic Agents
• Surgical Sealants and Adhesives
• Adhesion Barriers
• Staple Line Reinforcement

Breakup by Source:

• Natural/Biologics Products
• Synthetic Products

Breakup by Application:

• Orthopedic Surgery
• General Surgery
• Neurological Surgery
• Cardiovascular Surgery
• Gynecological Surgery
• Others

Breakup by End User:

• Hospitals
• Clinics
• Others

Breakup by Region:

• North America: (United States, Canada)
• Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

• B. Braun Melsungen AG
• Baxter International Inc.,
• Becton Dickinson and Company
• CryoLife Inc.
• CSL Limited
• Hemostasis LLC
• Integra Lifesciences Holdings Corporation
• Johnson & Johnson
• Medtronic plc
• Pfizer Inc.
• Sanofi S.A.
• Smith & Nephew plc
• Stryker Corporation
• Surgalign Spine Technologies Inc.

Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=4522&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/